An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants

Clinical trial NCT00613327 · COMPLETED

Trial details

NCT number: NCT00613327
Sponsor: Janssen Korea, Ltd., Korea
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2007-09-01
Primary completion: 2008-06-01
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.